GlassScriptPhysician profile
Lisa Chuong
NPI 1164087482
$2,141.34
in general payments reported to CMS, 2019-2025
24 companies · $980 in 2025
The $980 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $116 · 2022: $189 · 2023: $489 · 2024: $367 · 2025: $980.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,836.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $334.19 | 2025 | |
| Ferring Pharmaceuticals INC. | $189.10 | 2025 | Adstiladrin |
| Agiliti Surgical, INC. | $179.53 | 2024 | Sonablate Hifu |
| Teleflex LLC | $176.60 | 2023-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $143.28 | 2021-2024 | Xtandi |
| Olympus America INC. | $129.41 | 2023 | Itind System |
| Sumitomo Pharma America, INC. | $125.30 | 2023 | Orgovyx |
| Merck Sharp & Dohme LLC | $121.84 | 2023-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Pfizer INC. | $118.77 | 2023-2025 | |
| Janssen Biotech, INC. | $113.43 | 2022-2025 | Erleada, Carvykti |
| Photocure INC | $83.25 | 2022 | |
| Antares Pharma, INC. | $59.97 | 2025 | Xyosted |
| Exelixis INC. | $52.69 | 2023-2024 | Cabometyx |
| Boston Scientific Corporation | $48.06 | 2025 | Rezum Generator |
| Urogen Pharma, INC. | $47.90 | 2024-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $34.89 | 2025 | Eligard, Jatenzo |
| Genzyme Corporation | $32.19 | 2022 | |
| Tersera Therapeutics LLC | $28.39 | 2024 | Zoladex |
| 180 Medical, INC. | $27.93 | 2024 | |
| Blue Earth Diagnostics | $24.41 | 2023 | |
| Abbvie INC. | $20.96 | 2025 | |
| Progenics Pharmaceuticals, INC. | $18.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.94 | 2021 | |
| Myovant Sciences INC. | $14.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Chuong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.